TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial.
about
Hepatobiliary Tumors: Update on Diagnosis and ManagementTransarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patientsEfficacy of transcatheter arterial chemoembolization followed by sorafenib for intermediate/advanced hepatocellular carcinoma in patients in Japan: a retrospective analysis.Addition of n-butyl cyanoacrylate to classic transarterial chemoembolization may improve the radiological response in patients with hepatocellular carcinoma.TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progressionAspirin in combination with TACE in treatment of unresectable HCC: a matched-pairs analysis.A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.New treatment modalities for hepatocellular cancer.Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient.Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity.NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017Systemic treatment for hepatocellular carcinoma: Still unmet expectationsPharmacodynamics study of zedoary turmeric oil chitosan microspheres administered via arterial embolization.Role of liver-directed local tumor therapy in the management of hepatocellular carcinoma with extrahepatic metastases: a SEER database analysis.The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial.Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review.Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis.Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching.Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysisThe Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma
P2860
Q26775654-568CF630-BD78-47A5-91E5-AEFE81537E03Q26799469-A3E87800-1E7D-4F27-94B7-7B63377EAC94Q36210228-85079A49-E872-4B6A-8B27-21BA716705A9Q36364693-34178770-60F6-4366-96AD-8FFC1ECE04D7Q36413746-A5E46B29-5AD9-4023-A4F5-234B6600D210Q37298338-A34B3154-B743-4A63-928B-C7CD2C1ABEB7Q38375159-5941A31C-F50E-422C-874D-988EF21A4160Q38419200-007603E6-3C1C-4B46-874B-858C070A3C92Q38604896-63F6201D-8738-45C3-B2AF-75E5EA564D23Q38793468-0A2840F1-CAB4-4470-9C28-E9F9D93535ECQ38801422-5AFD3A5E-BC1B-4915-99D8-E4A134DBEA99Q39112745-552CF874-E05C-45FE-BBA3-1B698523AA91Q40247978-FCE243B1-0017-4838-9D88-AA7D39AF7542Q40481465-449C47F4-2C64-4B3B-A1D2-47C60C170D8CQ41172447-0780017F-951F-4315-8ABC-2D21E3870B51Q42053469-3EDAA9EF-FF0B-4171-908E-B59C23F8CE15Q42360747-EBFAE4CE-A951-405D-83F3-9A7C0734AE20Q42371684-ED35EDF8-21AD-45BA-822C-8D6243B2C677Q47158378-335951F7-DC6F-4DA2-B6CD-52A41128B92CQ52686882-FF583A9A-6D21-473C-BB41-5C64C5D6891BQ58765170-A6A6AA03-D97C-4E14-8DED-785D4995F433Q58797003-E45E671C-1363-4CC5-B94B-195FD6A74188
P2860
TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
TACE plus sorafenib for the tr ...... nter, phase II SOCRATES trial.
@en
TACE plus sorafenib for the tr ...... nter, phase II SOCRATES trial.
@nl
type
label
TACE plus sorafenib for the tr ...... nter, phase II SOCRATES trial.
@en
TACE plus sorafenib for the tr ...... nter, phase II SOCRATES trial.
@nl
prefLabel
TACE plus sorafenib for the tr ...... nter, phase II SOCRATES trial.
@en
TACE plus sorafenib for the tr ...... nter, phase II SOCRATES trial.
@nl
P2093
P2860
P1476
TACE plus sorafenib for the tr ...... nter, phase II SOCRATES trial.
@en
P2093
Andreas Erhardt
Christian Ohmann
Christiane Gog
Clemens Walter
Dirk Blondin
Eckart Schott
Frank Kolligs
Frank Lammert
Hennig Wege
Markus Schuchmann
P2860
P2888
P304
P356
10.1007/S00280-014-2568-8
P577
2014-08-31T00:00:00Z
P5875
P6179
1009369776